Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Span

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Mycoses|May 31, 2019
Posaconazole therapeutic drug monitoring in clinical practice and longitudinal analysis of the effect of routine laboratory measurements on posaconazole concentrationsAnne-Grete Märtson, Anette Veringa, Edwin R van den Heuvel, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 21, 2019
Ruxolitinib in Myelofibrosis and Baseline Thrombocytopenia in Real Life: Results in Dutch Patients and Review of the LiteratureStefanie Slot, Reinier A P Raymakers, Nicolaas Schaap, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 22, 2018
Role of FDG PET/CT in monitoring treatment response in patients with invasive fungal infectionsAlfred O Ankrah, Lambert F R Span, Hans C Klein, et al.
Clinical Chemistry|December 11, 2023
Hereditary Alpha Tryptasemia: Validation of a Single-Well Multiplex Digital Droplet PCR Assay in a Cohort of Symptomatic PatientsAbdulrazzaq Alheraky, Albertus T J Wierenga, Arjan Simpelaar, et al.
Therapeutic Drug Monitoring|February 5, 2016
Voriconazole Therapeutic Drug Monitoring Practices in Intensive CareMarjolijn J P van Wanrooy, Michael G G Rodgers, Lambert F R Span, et al.
The Journal of Antimicrobial Chemotherapy|September 8, 2016
Voriconazole metabolism is influenced by severe inflammation: a prospective studyAnette Veringa, Mendy Ter Avest, Lambert F R Span, et al.
Antimicrobial Agents and Chemotherapy|July 31, 2013
Dried blood spot analysis suitable for therapeutic drug monitoring of voriconazole, fluconazole, and posaconazoleKim C M van der Elst, Lambert F R Span, Kai van Hateren, et al.
Antimicrobial Agents and Chemotherapy|September 17, 2014
Inflammation is associated with voriconazole trough concentrationsMarjolijn J P van Wanrooy, Lambert F R Span, Michael G G Rodgers, et al.
Diagnostics (Basel, Switzerland)|January 22, 2021
The Added Value of [<sup>18</sup>F]FDG PET/CT in the Management of Invasive Fungal InfectionsAlfred O Ankrah, Dina Creemers-Schild, Bart de Keizer, et al.
Antimicrobial Agents and Chemotherapy|February 18, 2016
Longitudinal Analysis of the Effect of Inflammation on Voriconazole Trough ConcentrationsM A Encalada Ventura, M J P van Wanrooy, L F R Span, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Mycoses|May 31, 2019
Posaconazole therapeutic drug monitoring in clinical practice and longitudinal analysis of the effect of routine laboratory measurements on posaconazole concentrationsAnne-Grete Märtson, Anette Veringa, Edwin R van den Heuvel, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 21, 2019
Ruxolitinib in Myelofibrosis and Baseline Thrombocytopenia in Real Life: Results in Dutch Patients and Review of the LiteratureStefanie Slot, Reinier A P Raymakers, Nicolaas Schaap, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 22, 2018
Role of FDG PET/CT in monitoring treatment response in patients with invasive fungal infectionsAlfred O Ankrah, Lambert F R Span, Hans C Klein, et al.
Clinical Chemistry|December 11, 2023
Hereditary Alpha Tryptasemia: Validation of a Single-Well Multiplex Digital Droplet PCR Assay in a Cohort of Symptomatic PatientsAbdulrazzaq Alheraky, Albertus T J Wierenga, Arjan Simpelaar, et al.
Therapeutic Drug Monitoring|February 5, 2016
Voriconazole Therapeutic Drug Monitoring Practices in Intensive CareMarjolijn J P van Wanrooy, Michael G G Rodgers, Lambert F R Span, et al.
The Journal of Antimicrobial Chemotherapy|September 8, 2016
Voriconazole metabolism is influenced by severe inflammation: a prospective studyAnette Veringa, Mendy Ter Avest, Lambert F R Span, et al.
Antimicrobial Agents and Chemotherapy|July 31, 2013
Dried blood spot analysis suitable for therapeutic drug monitoring of voriconazole, fluconazole, and posaconazoleKim C M van der Elst, Lambert F R Span, Kai van Hateren, et al.
Antimicrobial Agents and Chemotherapy|September 17, 2014
Inflammation is associated with voriconazole trough concentrationsMarjolijn J P van Wanrooy, Lambert F R Span, Michael G G Rodgers, et al.
Diagnostics (Basel, Switzerland)|January 22, 2021
The Added Value of [<sup>18</sup>F]FDG PET/CT in the Management of Invasive Fungal InfectionsAlfred O Ankrah, Dina Creemers-Schild, Bart de Keizer, et al.
Antimicrobial Agents and Chemotherapy|February 18, 2016
Longitudinal Analysis of the Effect of Inflammation on Voriconazole Trough ConcentrationsM A Encalada Ventura, M J P van Wanrooy, L F R Span, et al.
Pageof 4